As of 2024-12-15, the Fair Value of Global Blood Therapeutics Inc (GBT) is -23.89 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 68.49 USD, the upside of Global Blood Therapeutics Inc is -134.89%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 5Y Avg | |
| Net income | -117.00 | -174.20 | -266.80 | -247.60 | -303.09 | -221.74 |
| YoY growth | -41.82% | -48.89% | -53.16% | 7.20% | -22.41% | -31.82% |
| Market Cap (mil) | 4,621.43 |
| P/E | |
| Forward P/E | -14.30x |
| EPS | -4.78 |
| Avg earnings growth rate | -31.82% |
| TTM earnings | -322.46 |